Post #324

Genesis Therapeutic — a startup working on GNN drug discovery Launched in November 2019 out of Stanford’s Pande Lab, Genesis Therapeutics is researching GNNs and graph generative models in the field of drug discovery. They recently announced their partnership with Genentech, large biotech company, to test their ML platform for pharma.